Screening compound: HHDPYFWVEUBYNP-UHFFFAOYSA-N

Screening compound: HHDPYFWVEUBYNP-UHFFFAOYSA-N
Screening compound: HHDPYFWVEUBYNP-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
HHDPYFWVEUBYNP-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L871-0013

Molecular Formula

C24H26N4O5S (C24 H26 N4 O5 S)

Compound Name

N-{[5-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]methyl}-N-phenylacetamide

IUPAC name

N-{[5-(23-dihydro-14-benzodioxine-6-sulfonyl)-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridin-3-yl]methyl}-N-phenylacetamide

SMILES

CC(N(Cc1nn(C)c(CC2)c1CN2S(c(cc1)cc2c1OCCO2)(=O)=O)c1ccccc1)=O

InChI

InChI=1S/C24H26N4O5S/c1-17(29)28(18-6-4-3-5-7-18)16-21-20-15-27(11-10-22(20)26(2)25-21)34(30,31)19-8-9-23-24(14-19)33-13-12-32-23/h3-9,14H,10-13,15-16H2,1-2H3

InChI Key

HHDPYFWVEUBYNP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27483087

HHDPYFWVEUBYNP-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with HHDPYFWVEUBYNP-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound HHDPYFWVEUBYNP-UHFFFAOYSA-N?
Check Price and Availability of HHDPYFWVEUBYNP-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of HHDPYFWVEUBYNP-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for HHDPYFWVEUBYNP-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for HHDPYFWVEUBYNP-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of HHDPYFWVEUBYNP-UHFFFAOYSA-N available by request